Monday, September 26, 2022

SARS-CoV-2

Remdesivir shows early promise in the fight against COVID-19

Remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19.

Neurological complications of COVID-19 can include delirium, rare brain inflammation and stroke

Preliminary clinical data indicate that COVID-19 infection is associated with neurological and neuropsychiatric illness. Now a new study by the UCL and UCLH suggests...

A new robotic system that powerfully disinfects large surfaces in half an hour

A team from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL), in collaboration with Ava Robotics and the Greater Boston Food Bank (GBFB), designed...

COVID-19 might emerge from shuffling and selection of viral genes across different species

Understanding the origins of SARS-CoV-2 is critical for deterring future zoonosis, discovering new drugs, and developing a vaccine. According to a new study, a combination...

How SARS-CoV-2 interact with a host cell?

Using single-cell RNA sequencing, scientists at the Yale School of Medicine (YSM) are learning single-cell RNA sequencing of infected human bronchial epithelial cells (HBECs)...

First human trial of COVID-19 vaccine found to be safe and effective

The first COVID-19 vaccine called adenovirus type-5 (Ad5) vectored COVID-19 vaccine that underwent a phase 1 clinical trial found to be safe, well-tolerated and...

Mouthwash can halt the transmission of COVID-19

SARS-CoV-2 is an enveloped virus, characterized by an outer lipid membrane derived from the host cell from which it buds. While it is highly sensitive...

Human immune system can recognize coronavirus in many ways

While documenting a robust antiviral immune response to SARS-CoV-2, scientists at La Jolla Institute for Immunology have found that the body's immune system can...

The study explains why Coronavirus is so transmissible between people

A new study by the Cornell University- identifying structural loop in the SARS-CoV-2 spike protein- structural loop in the SARS-CoV-2 spike protein. The study...

Recovered COVID-19 patients produce virus-specific antibodies and T cells

A new study has found that recently discharged patients with Coronavirus produce virus-specific antibodies and T cells. It remains unclear why immune responses generally varied...

This antibody prevents SARS-CoV-2 virus from infecting cultured cells

A fully human monoclonal antibody prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells, suggests a new study by the Utrecht University. This finding is...

Antibody produced by llamas could neutralize coronavirus

According to a new study, a special kind of antibody produced by llamas could help fight against COVID-19. The antibody binds firmly to an...

Recent Stories